Company Analysis

CDT Equity Inc. (CDT)

Nasdaq: CDT · Pharmaceutical Preparations · Naples, FL · filing with the SEC since 2021
Grade3.3
◀ Past 2.5● Present 1.8▶ Future 5.0
6 est.

Who runs CDT Equity Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Regan Andrew
Chief Executive Officer. First filing Sep 2023, latest Oct 27, 2026, 2 filings in all.
Officers reporting now
2
of 6 people with a filing in the last fifteen months
Directors reporting now
4
14 people on the record since 2022
Officerssales are open-market, Oct 27, 2025 to Oct 27, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Regan AndrewChief Executive OfficerSep 2023Oct 27, 20262 · $0.00
Bligh JamesCFOSep 2023Sep 19, 2025none
Directorssales are open-market, Oct 27, 2025 to Oct 27, 2026
NameRoleFirst filingLatest filingSales, 12 months
Olsen Ulrik KdirectorApr 2026Apr 30, 2026none
Farley Chele ChiavaccidirectorFeb 2022Feb 23, 2026none
Fry Simon JeremydirectorDec 2024Aug 26, 2025none
Lewis-Hall Freda CdirectorSep 2023Aug 26, 2025none
Owners of more than 10% of a classsales are open-market, Oct 27, 2025 to Oct 27, 2026
NameRoleFirst filingLatest filingSales, 12 months
Corvus Capital Ltd.10% ownerSep 2023Oct 27, 2026none
Prospect Capital Securities Ltd10% ownerFeb 2026Jun 23, 20264 · $2.9M
Prospect Finance Ltd10% ownerFeb 2026Jun 23, 2026none
Taylor Mark Andrew10% ownerFeb 2026Jun 23, 2026none
Earlier names on the record17, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CDT · research, not advice